RYTM - RHYTHM PHARMACEUTICALS, INC.

QQQ $ 608.45 $ 0.46 (0.08 %)

DIA $ 471.65 $ -2.94 (-0.62 %)

SPY $ 671.62 $ -0.11 (-0.02 %)

TLT $ 88.93 $ -0.51 (-0.57 %)

GLD $ 375.82 $ -6.91 (-1.8 %)

Previous Close

$ 99.41

Open

$ 95.46

Bid

$ 99.94 x 10

Ask

$ 100.17 x 108

Day's Range

$ 97.34 - $ 101.95

52 Week Range

$ 45.91 - $ 116.00

Volume

768,479

Average Volume

Market Cap

6.63B

Beta (5Y Monthly)

$ 1.50

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	11-04-2025	09-30-2025	10-Q
2	08-05-2025	06-30-2025	10-Q
3	05-07-2025	03-31-2025	10-Q
4	02-28-2025	01-01-1970	10-K
5	11-06-2024	09-30-2024	10-Q
6	08-06-2024	06-30-2024	10-Q
7	05-07-2024	03-31-2024	10-Q
8	02-29-2024	12-31-2023	10-K
9	11-08-2023	09-30-2023	10-Q
10	08-01-2023	06-30-2023	10-Q
11	05-02-2023	03-31-2023	10-Q
12	03-01-2023	12-31-2022	10-K
13	11-08-2022	09-30-2022	10-Q
14	08-03-2022	06-30-2022	10-Q
15	05-03-2022	03-31-2022	10-Q
16	03-01-2022	12-31-2021	10-K
17	11-02-2021	09-30-2021	10-Q
18	08-03-2021	06-30-2021	10-Q
19	05-03-2021	03-31-2021	10-Q
20	03-01-2021	12-31-2020	10-K
21	11-02-2020	09-30-2020	10-Q
22	08-03-2020	06-30-2020	10-Q
23	05-04-2020	03-31-2020	10-Q
24	03-02-2020	12-31-2019	10-K
25	11-01-2019	09-30-2019	10-Q
26	07-29-2019	06-30-2019	10-Q
27	05-03-2019	03-31-2019	10-Q
28	03-08-2019	12-31-2018	10-K
29	11-09-2018	09-30-2018	10-Q
30	08-08-2018	06-30-2018	10-Q
31	05-14-2018	03-31-2018	10-Q
32	03-12-2018	12-31-2017	10-K
33	11-14-2017	09-30-2017	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Canaccord Genuity Maintains Buy on Rhythm ...
11/10/2025 20:36:24

Canaccord Genuity analyst Whitney Ijem maintains Rhythm Pharmaceuticals (NASDAQ:RYTM) with a Buy and raises the price target...

Rhythm Pharmaceuticals Data From Phase 3 T...
11/10/2025 12:14:28

Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the li...

Needham Maintains Buy on Rhythm Pharmaceut...
11/07/2025 19:45:05

Needham analyst Joseph Stringer maintains Rhythm Pharmaceuticals (NASDAQ:RYTM) with a Buy and lowers the price target from $...

Rhythm Pharmaceuticals Announces FDA Exten...
11/07/2025 12:31:16

Rhythm Pharmaceuticals Signs Agreements Wi...
11/05/2025 21:15:10

Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the li...

Needham Maintains Buy on Rhythm Pharmaceut...
11/04/2025 17:06:06

Needham analyst Joseph Stringer maintains Rhythm Pharmaceuticals (NASDAQ:RYTM) with a Buy and raises the price target from $...

Rhythm Pharmaceuticals Q3 EPS $(0.82) Miss...
11/04/2025 12:00:36

Rhythm Pharmaceuticals (NASDAQ:RYTM) reported quarterly losses of $(0.82) per share which missed the analyst consensus estimate...

Earnings Scheduled For November 4, 2025
11/04/2025 11:12:08

Rhythm Pharmaceuticals's Earnings: A Preview
11/03/2025 19:01:18

Goldman Sachs Maintains Buy on Rhythm Phar...
10/17/2025 17:21:28

Goldman Sachs analyst Corinne Jenkins maintains Rhythm Pharmaceuticals (NASDAQ:RYTM) with a Buy and lowers the price target ...

Morgan Stanley Maintains Overweight on Rhy...
10/16/2025 18:01:46

Morgan Stanley analyst Jeffrey Hung maintains Rhythm Pharmaceuticals (NASDAQ:RYTM) with a Overweight and raises the price ta...

HC Wainwright & Co. Maintains Buy on Rhyth...
09/29/2025 10:31:24

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Rhythm Pharmaceuticals (NASDAQ: RYTM) with a Buy and raises the...

Morgan Stanley Maintains Overweight on Rhy...
09/25/2025 17:54:10

Morgan Stanley analyst Jeffrey Hung maintains Rhythm Pharmaceuticals (NASDAQ: RYTM) with a Overweight and raises the price t...

JMP Securities Maintains Market Outperform...
09/25/2025 13:13:08

JMP Securities analyst Jonathan Wolleben maintains Rhythm Pharmaceuticals (NASDAQ: RYTM) with a Market Outperform and raises...

Goldman Sachs Maintains Buy on Rhythm Phar...
09/24/2025 18:01:13

Goldman Sachs analyst Corinne Jenkins maintains Rhythm Pharmaceuticals (NASDAQ:RYTM) with a Buy and raises the price target ...

Peering Into Rhythm Pharmaceuticals's Rece...
09/11/2025 17:01:03

Rhythm Pharmaceuticals Announces The FDA H...
08/20/2025 20:03:53

U.S. Food and Drug Administration accepts sNDA for filing with priority review; sets PDUFA goal date of December 20, 2025 --– E...

HC Wainwright & Co. Maintains Buy on Rhyth...
08/07/2025 11:58:45

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Rhythm Pharmaceuticals (NASDAQ:RYTM) with a Buy and raises the ...

12 Analysts Have This To Say About Rhythm ...
08/06/2025 21:04:06

Morgan Stanley Maintains Overweight on Rhy...
08/06/2025 16:30:58

Morgan Stanley analyst Jeffrey Hung maintains Rhythm Pharmaceuticals (NASDAQ:RYTM) with a Overweight and raises the price ta...